Services described
The following services are described in this clause:
(I)#
Chemotherapy administration services.
(II)#
Renal dialysis services (as defined in section 1395rr(b)(14)(B) of this title ).
(III)#
Skilled nursing care.
(IV)#
Clinical diagnostic laboratory test administered during any portion of the emergency period defined in paragraph (1)(B) of section 1320b–5(g) of this title beginning on or after March 18, 2020 , for the detection of SARS–CoV–2 or the diagnosis of the virus that causes COVID–19 and the administration of such test.
(V)#
Specified COVID–19 testing-related services (as described in section 1395 l (cc)(1) of this title) for which payment would be payable under a specified outpatient payment provision described in section 1395 l (cc)(2) of this title.
(VI)#
A COVID–19 vaccine and its administration described in section 1395x(s)(10)(A) of this title .
(VII)#
A drug or biological product that is a selected drug (as referred to in section 1320f–1(c) of this title ).
(VIII)#
Such other services that the Secretary determines appropriate (including services that the Secretary determines require a high level of predictability and transparency for beneficiaries).